相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence
Eugen Dhimolea et al.
CANCER CELL (2021)
Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy
Sumaiyah K. Rehman et al.
CELL (2021)
The role of endolysosomal trafficking in anticancer drug resistance
Noor A. Hussein et al.
DRUG RESISTANCE UPDATES (2021)
Cycling cancer persister cells arise from lineages with distinct programs
Yaara Oren et al.
NATURE (2021)
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
Joanna Kopecka et al.
DRUG RESISTANCE UPDATES (2020)
Advanced technological tools to study multidrug resistance in cancer
Luca Andrei et al.
DRUG RESISTANCE UPDATES (2020)
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Jinyun Dong et al.
DRUG RESISTANCE UPDATES (2020)
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Sabrina Dallavalle et al.
DRUG RESISTANCE UPDATES (2020)
Persistent Cancer Cells: The Deadly Survivors
Shensi Shen et al.
CELL (2020)
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism
Douglas B. Fox et al.
NATURE METABOLISM (2020)
Definitions and guidelines for research on antibiotic persistence
Nathalie Q. Balaban et al.
NATURE REVIEWS MICROBIOLOGY (2019)
What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
Teodora Alexa-Stratulat et al.
DRUG RESISTANCE UPDATES (2019)
Adaptive evolution reveals a tradeoff between growth rate and oxidative stress during naphthoquinone-based aerobic respiration
Amitesh Anand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Targeting Cancer Cell Dormancy
Ariadna Recasens et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells
Shensi Shen et al.
NATURE COMMUNICATIONS (2019)
Repurposing Brigatinib for the Treatment of Colorectal Cancer Based on Inhibition of ER-phagy
Zhe Zhang et al.
THERANOSTICS (2019)
Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance
Nobuaki Takahashi et al.
CANCER CELL (2018)
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
Liqin Wang et al.
CELL (2018)
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
Hai Wang et al.
NATURE COMMUNICATIONS (2018)
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
Tyler Risom et al.
NATURE COMMUNICATIONS (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Inhibiting Cholesterol Absorption During Lactation Programs Future Intestinal Absorption of Cholesterol in Adult Mice
Lidiya G. Dimova et al.
GASTROENTEROLOGY (2017)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S. Viswanathan et al.
NATURE (2017)
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
Remy Nicolle et al.
CELL REPORTS (2017)
Nanotechnology for Multimodal Synergistic Cancer Therapy
Wenpei Fan et al.
CHEMICAL REVIEWS (2017)
Rational Design of Metal Organic Framework Nanocarrier-Based Codelivery System of Doxorubicin Hydrochloride/Verapamil Hydrochloride for Overcoming Multidrug Resistance with Efficient Targeted Cancer Therapy
Huiyuan Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova et al.
NATURE CHEMICAL BIOLOGY (2016)
Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs
Nisebita Sahu et al.
NATURE COMMUNICATIONS (2016)
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
Debasish Raha et al.
CANCER RESEARCH (2014)
Epigenetic Modulation of Intestinal Cholesterol Transporter Niemann-Pick C1-like 1 (NPC1L1) Gene Expression by DNA Methylation
Pooja Malhotra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1
Pei-Shan Li et al.
NATURE MEDICINE (2014)
Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5
Dong-Yun Ouyang et al.
AUTOPHAGY (2013)
Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake
Liang Ge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Is resistance useless? Multidrug resistance and collateral sensitivity
Matthew D. Hall et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Niemann-Pick C1-like 1 mediates α-tocopherol transport
Kazuya Narushima et al.
MOLECULAR PHARMACOLOGY (2008)
The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines
Masashi Takeda et al.
PROSTATE (2007)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs
V Gouazé et al.
CANCER RESEARCH (2005)
分享论文
